Does leptin contribute to obesity hypertension?

Current Opinion in Endocrinology and Diabetes

Volumn 6, Issue 3, 1999, Pages 225-229

  Hall, John E ^a   Shek, Eugene W M ^a   Brands, Michael W ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; MELANOCORTIN RECEPTOR;

ADOLESCENT; ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPOTHALAMUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; OBESITY; RAT; WEIGHT REDUCTION;

EID: 0033039481     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199906000-00010     Document Type: Article

References (29)

1. Hall JE, Brands MW, Henegar JR, Shek EW: Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol 1998; 25:58-64. This review summarizes the mechanisms by which obesity causes hypertension and provides evidence that the renal sympathetic nerves mediate much of the increase in blood pressure associated with a long-term high-fat diet.
2. Garrison RJ, Kannet WB, Stokes J, Castelli WP: Incidence and precursors of hypertension in young adults: The Framingham offspring study. Prev Med 1987, 16:234-251.
3. Hall JE: Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 1997, 10:S49-S55.
4. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL: Sympathetic and cardiorenal actions of leptin. Hypertension 1997, 30(part II):619-623.
5. Haynes WG, Morgan DA, Walsh SA, Sivitz WI, Mark AL: Cardiovascular consequences of obesity: Role of leptin. Clin Exp Pharmacol Physiol 1998, 25:65-69. This article reviews evidence linking leptin to increased sympathetic activity in obesity hypertension.
6. Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG: Obesity-induced hypertension: New concepts from the emerging biology of obesity. Hypertension 1999, 33(part II):537-541. This review focuses on the neurobiology of obesity and suggests that the effect of weight gain to increase blood pressure is critically dependent on genetic background and leptin-mediated sympathetic activation.
7. Dunbar JC, Hu Y, Lu R: Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997, 46:2040-2043.
8. Casto RM, VanNess JM, Overton JM: Effects of central leptin administration on blood pressure in normotensive rats. Neurosc Lett 1998, 246:29-32.
9. Lembo G, Vecchione C, Fratta L, Marino G, Santic DD, Trimarco B: Leptin induces nitric-oxide mediated vasorelaxation in aortic-rings of WKY rats (abstract). Hypertension 1998, 32:599.
10. Flier JS, Maratos-Flier E: Obesity and the hypothalumus: Novel peptides for new pathways. Cell 1998, 92:437-440. The action of leptin in the hypothalamus and interactions with newly discovered neuropeptides are reviewed.
11. Erickson JC, Hollopeter G, Palmiter RD: Attenuation of the obesity syndrome of ob/ob mice mice by the loss of neuropeptide Y. Science 1996, 274:1704-1707.
12. McAuley MA, Chen X, Westfall TC: Central cardiovascular actions of neurepeptide Y. In The Biology of Neuropeptide Y and Related Peptides. Edited by Colmers WF, Wahlestedt C. Humana Press: New Jersey; 1993:389-418.
13. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
14. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385:165-168.
15. Thornton JE, Chueng CC, Clifton DK, Steiner RA: Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Nature 1994, 372:425-432.
16. Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL: Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999, 33(part 11):542-547. Short-term intracerebroventricular leptin administration increased renal sympathetic nerve activity, but not brown adipose tissue sympathetic activity, through activation of hypothalamic melanocortin receptors.
17. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS: Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocrine Rev 1999, 20(1):68-100.
18. Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 1998, 31(part 11):409-414. This study shows that long-term intravenous or carotid artery infusions of leptin, at doses calculated to mimic the plasma concentrations in obesity, significantly increased heart rate and arterial pressure while reducing food intake in rats.
19. Ogawa Y, Masuzaki H, Aizawa M, Yura S, Satoh N, Iwai H, Hosoda K, Nakao K: Blood pressure elevation in transgenci mice over-expressing leptin, the obese gene product (abstract). J Hypertens 1998, 16:S7.
20. Shek EW, Kim PK, Hall JE: Adrenergic blockade prevents leptin-induced hypertension. Fed Proc 1999, 13:A780.
21. Jackson EK, Li P: Human leptin has natriuretic activity in the rat. Am J Physiol 1997, 272:F333-F338.
22. Villareal D, Reams G, Freeman RH, Taraben A: Renal effects of leptin in normotensive, hypertensive, and obese rats. Am J Physiol 1998, 275:R2056-R2060.
23. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PO, Sinha MK, Considine RV: Decreased cerebrospinal-fluid/serum leptin rat in obesity: A possible mechanism for leptin resistance. Lancet 1996, 348:159-161.
24. VanHeek M, Comptom DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, Davis HR: Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997, 99:385-390.
25. Lu H, Duanmu Z, Houck C, Jen KL, Buison A, Dunbar JC: Obesity due to high fat diet decreases the sympathetic nervous and cardiovascular responses to intracerebroventricular leptin in rats. Brain Res Bull 1998, 47(4):331-335. In rats that were fed a high-fat diet, the increased lumbar sympathetic nerve activity found during intracerebroventricular leptin administration was attenuated when compared with rats that were fed normal chow.
26. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP: Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995, 25:893-897.
27. Hirose H, Saito I, Tsujioka M, Mori M, Kawabe H, Saruta T: The obese gene product, leptin: Possible role in obesity-related hypertension in adolescents. J Hypertens 1999, 16:2007-2012.
28. Suter PM, Locher R, Häsler E, Vetter W: Is there a role for the ob gene product leptin in essential hypertension? Am J Hypertens 1998, 11:1305-1311. In 139 subjects (110 with essential hypertension and 29 nonhypertensive controls), systolic blood pressure correlated with plasma leptin, even after adjustment for body weight, in women and in nonhypertensive men only.
29. Onions KL, Hunt SC, Rutkowski MP, Klanke CA, Su YR, Reif M, Menon AG: Genetic markers at the leptin (ob) locus are not significantly linked to hypertension in African Americans. Hypertension 1998, 31:1230-1234.